Showing results (61-70 of 242) with videos related to
Sort By:
Pageof 25
Cancer Drug Delivery|January 1, 1984
Combination intracavitary chemotherapy for malignant pleural diseaseM Markman, S B Howell, M R GreenCancer Research|October 1, 1979
Activity of thymidine as a chemotherapeutic agent against human tumor xenografts in nude miceS B Howell, R S Jenkins, J StreifelThe Journal of Biological Chemistry|March 5, 1990
Increased sensitivity to cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells in response to treatment with 12-O-tetradecanoylphorbol 13-acetateS Isonishi, P A Andrews, S B HowellClinical Pharmacology and Therapeutics|March 1, 1984
Kinetics of sodium thiosulfate, a cisplatin neutralizerM Shea, J A Koziol, S B HowellCancer Chemotherapy and Pharmacology|January 1, 1987
Modulation of the peritoneal clearance of liposomal cytosine arabinoside by blank liposomesS Kim, D J Kim, S B HowellJournal of Peptide Science : an Official Publication of the European Peptide Society|February 16, 2000
Synthesis, conformational analysis and bioactivity of Lan-7, a lanthionine analog of TT-232H Li, X Jiang, S B Howell, et al.Annals of Internal Medicine|July 1, 1984
Intraperitoneal chemotherapy with melphalanS B Howell, C E Pfeifle, R A OlshenBritish Journal of Cancer|January 19, 2000
Depletion of protein kinase C (PKC) by 12-O-tetradecanoylphorbol-13-acetate (TPA) enhances platinum drug sensitivity in human ovarian carcinoma cellsS Isonishi, K Ohkawa, T Tanaka, et al.Cancer Chemotherapy and Pharmacology|January 1, 1984
Pharmacokinetics and toxicity of 5-day continuous infusion of vinblastineJ A Young, S B Howell, M R GreenMolecular Pharmacology|December 1, 1986
Differential sensitization of human ovarian carcinoma and mouse L1210 cells to cisplatin and melphalan by glutathione depletionP A Andrews, M P Murphy, S B HowellPageof 25